Published in Thromb Haemost on February 28, 1978
Disseminated intravascular coagulation: diagnosis and treatment. BMJ (1996) 1.41
Diagnosis of overt disseminated intravascular coagulation: a comparative study using criteria from the International Society versus the Korean Society on Thrombosis and Hemostasis. Yonsei Med J (2007) 0.94
Association between necropsy evidence of disseminated intravascular coagulation and coagulation variables before death in patients in intensive care units. J Clin Pathol (1988) 0.93
Obstructive sleep apnea syndrome: blood viscosity, blood coagulation abnormalities, and early atherosclerosis. Lung (2012) 0.85
A spontaneous intercostal artery hemorrhage in systemic lupus erythematosus. Rheumatol Int (2011) 0.84
Human platelet aggregation is initiated by peripheral blood mononuclear cells exposed to bacterial lipopolysaccharide in vitro. J Clin Invest (1986) 0.82
Prothrombin time derived fibrinogen determination on Sysmex CA-6000. J Clin Pathol (1998) 0.81
Hepatic manifestations in hematological disorders. Int J Hepatol (2013) 0.79
Septic shock. Can Fam Physician (1980) 0.75
Thromboelastometry-guided blood transfusion in septic shock complicated with disseminated intravascular coagulation: a case report. Clin Case Rep (2017) 0.75
Pathophysiology of intravascular coagulation and fibrinolysis. J Clin Pathol Suppl (R Coll Pathol) (1980) 0.75
DIAGNOSING DISSEMINATED INTRAVASCULAR COAGULATION IN ACUTE INFECTION : CAN WE DO WITHOUT FDP & D-DIMER. Med J Armed Forces India (2011) 0.75
Blood Components Load in Post-operative Neurosurgical Patients Suspected with Disseminated Intravascular Coagulation. Indian J Hematol Blood Transfus (2017) 0.75
New-onset acute thrombocytopenia in hospitalized patients: pathophysiology and diagnostic approach. J Community Hosp Intern Med Perspect (2017) 0.75
Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology (1999) 5.34
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest (1985) 3.85
Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med (1978) 3.64
Defined medium for growth of Haemophilus influenzae. J Bacteriol (1970) 3.08
Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM (1996) 2.54
Numb chin syndrome in cancer patients: etiology, response to treatment, and prognostic significance. Neurology (1992) 2.53
Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation (1993) 2.42
Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis. N Engl J Med (1996) 2.38
Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell (1998) 2.34
Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med (1986) 2.29
Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med (1984) 2.26
False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Thromb Haemost (2009) 2.14
Inherited thrombophilia: Part 1. Thromb Haemost (1996) 2.00
Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Eur Heart J (1995) 1.90
Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol (2010) 1.85
The central visual field in homonymous hemianopia. Evidence for unilateral foveal representation. Arch Neurol (1997) 1.59
Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. J Am Coll Cardiol (1990) 1.58
Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med (1991) 1.56
Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye (Lond) (1999) 1.54
Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Ann Oncol (2007) 1.47
Altered transcription of an oncogene in chronic myeloid leukaemia. Lancet (1984) 1.46
Point mutations regarded as missense mutations cause splicing defects in the factor XI gene. J Thromb Haemost (2011) 1.46
Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis. Ann Intern Med (1982) 1.44
Effect of past and concurrent body mass index on prevalence of glucose intolerance and type 2 (non-insulin-dependent) diabetes and on insulin response. The Israel study of glucose intolerance, obesity and hypertension. Diabetologia (1986) 1.44
Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology (2008) 1.44
Multiple myeloma in the geriatric patient. Cancer (1990) 1.44
Antibodies to Herpes simplex virus in Jewish women with cervical cancer and in healthy Jewish women of Israel. J Natl Cancer Inst (1975) 1.43
Age estimates of two common mutations causing factor XI deficiency: recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews. Am J Hum Genet (1999) 1.38
Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experience. Isr J Med Sci (1995) 1.38
Inherited thrombophilia: Part 2. Thromb Haemost (1996) 1.34
Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. J Am Coll Cardiol (1993) 1.33
Anterior decompression of the spine for metastatic epidural cord compression: a promising avenue of therapy? Ann Neurol (1982) 1.29
Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience. Br J Ophthalmol (2008) 1.29
Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood (1991) 1.28
Inherited platelet disorders. Haemophilia (2012) 1.27
Errors in computing drug doses. Can Med Assoc J (1983) 1.26
Screening for NIDDM. Why is there no national program. Diabetes Care (1994) 1.25
Body weight reduction necessary to attain normotension in the overweight hypertensive patient. Int J Obes (1981) 1.22
Low-fiber intake as an etiologic factor in cancer of the colon. J Natl Cancer Inst (1975) 1.21
Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost (1987) 1.17
EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol (2006) 1.17
A Glanzmann's thrombasthenia cluster among Iraqi Jews in Israel. Thromb Haemost (1984) 1.17
Surgical decompression of anterior and posterior malignant epidural tumors compressing the spinal cord: a prospective study. Neurosurgery (1985) 1.16
Effectiveness of glycosylated hemoglobin, fasting plasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance. Am J Epidemiol (1984) 1.15
Carrier frequency of the IVS4 + 4 A-->T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population. Blood (1995) 1.15
Dubin-Johnson syndrome in Israel. I. Clinical, laboratory, and genetic aspects of 101 cases. Q J Med (1970) 1.14
Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease. Ann Rheum Dis (2004) 1.13
Vertebral body resection for epidural compression by malignant tumors. Results of forty-seven consecutive operative procedures. J Bone Joint Surg Am (1985) 1.12
Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem (1997) 1.12
The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci U S A (1991) 1.12
Risk factors associated with postpartum ovarian vein thrombosis. Thromb Haemost (1999) 1.11
Familial aggregation of haematological neoplasms: a controlled study. Br J Haematol (1994) 1.10
The improving outcome of triplet pregnancies. Am J Obstet Gynecol (1989) 1.10
Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy. Cancer (1998) 1.09
Central nervous system involvement in indolent lymphomas. Ann Oncol (2005) 1.09
Increased risk of lung cancer in patients with chondromatous hamartoma. J Thorac Cardiovasc Surg (1980) 1.09
Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. Blood (1979) 1.07
The role of factor XI in thrombin generation induced by low concentrations of tissue factor. Thromb Haemost (2001) 1.06
Incidence of hyperkalemia in hospitalized patients. Isr J Med Sci (1983) 1.06
Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy. Thromb Res (1987) 1.06
Metabolic and calcium kinetic studies in idiopathic hypercalciuria. J Clin Invest (1968) 1.04
Failure to detect variant (CRM+) plasma thromboplastin antecedent (factor XI) molecules in hereditary plasma thromboplastin antecedent deficiency: a study of 125 patients of several ethnic backgrounds. J Lab Clin Med (1985) 1.04
Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII. J Clin Invest (1979) 1.04
Abnormal excretion of the isomers of urinary coproporphyrin by patients with Dubin-Johnson syndrome in Israel. Clin Sci (1971) 1.03
Leptomeningeal metastases--treatment results in 98 consecutive patients. Isr J Med Sci (1989) 1.01
Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol (1999) 1.01
Immunological studies in combined factor V and factor VIII deficiency. Br J Haematol (1977) 1.00
Combined factor V and factor VIII deficiency among non-Ashkenazi Jews. N Engl J Med (1982) 1.00
Current considerations in the management of neoplastic spinal cord compression. Spine (Phila Pa 1976) (1989) 0.99
Spermarche--the age of onset of sperm emission. J Adolesc Health Care (1985) 0.98
Responses of platelets to strains of streptococcus sanguis: findings in healthy subjects, Bernard-Soulier, Glanzmann's, and collagen-unresponsive patients. Thromb Haemost (1987) 0.97
The diagnostic value of sperm in post-ejaculatory urine. Int J Androl (1984) 0.96
High gene frequency of factor XI (PTA) deficiency in Ashkenazi Jews. Blood (1978) 0.96
Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial. J Neurooncol (2006) 0.95
Mendelian diseases among Roman Jews: implications for the origins of disease alleles. J Clin Endocrinol Metab (1999) 0.95
Clinical and genetic aspects of Glanzmann's thrombasthenia in Israel: report of 22 cases. Thromb Diath Haemorrh (1975) 0.95
Rare bleeding disorders. Haemophilia (2006) 0.95
Spontaneous involution of an intra-axial brain stem lesion: a case report. Pediatr Neurosurg (1995) 0.95
Erysipelas. Changing faces. Int J Dermatol (1985) 0.94
Inherited factor XI deficiency confers no protection against acute myocardial infarction. J Thromb Haemost (2003) 0.94
Linkage of combined factors V and VIII deficiency to chromosome 18q by homozygosity mapping. J Clin Invest (1997) 0.94
The effects of nosocomial infections on the length and costs of hospital stay. J Antimicrob Chemother (1982) 0.94
Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males. Blood (1999) 0.94
ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families. Blood (1999) 0.93
The incidence of insulin-dependent diabetes mellitus in Israeli children and adolescents 0-20 years of age: a retrospective study, 1975-1980. Diabetes Care (1985) 0.93
Prenatal diagnosis of Glanzmann's thrombasthenia. Lancet (1986) 0.93
A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood (1997) 0.93
Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency. J Thromb Haemost (2014) 0.93
The mechanism of benign hereditary neutropenia. Arch Intern Med (1982) 0.92
Clinical significance of diffuse dural enhancement detected by magnetic resonance imaging. J Neurosurg (1996) 0.92